Navigating the regulatory complexities of targeted medicines in oncology

Join us for an insightful webinar on Wednesday, May 14, 2025, at 11 am ET. In this webinar, Chris Englerth, our Director of Global Consulting Services, will moderate the session alongside Christian Schneider, MD, our Chief Medical Officer for Strategic Product Development Consulting. The future of targeted medicines holds promise, and as the landscape continues to evolve, understanding key non-clinical and clinical considerations is more critical than ever. Join our upcoming webinar to explore the strategic considerations for successfully navigating the regulatory complexities of targeted medicines.

Key learnings

  • An introduction and understanding of targeted medicines
  • The challenge in translational medicine for non-clinical development of targeted medicines
  • Key clinical development considerations of targeted medicines

PharmaLex joins Cencora

PharmaLex is now part of Cencora, a global leader in pharmaceutical solutions focused on improving lives worldwide. This integration enhances Cencora’s offerings for the pharma, biotech, and medtech industries. PharmaLex support clients from early strategic planning and non-clinical requirements through clinical development, regulatory submissions, and post-approval activities, utilizing technology-driven solutions throughout the product lifecycle.

Related resources

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.